BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM $310M
1-Year Return
6.98%
This Quarter Return
+29.19%
1 Year Return
+6.98%
3 Year Return
+59.66%
5 Year Return
–
10 Year Return
–
AUM
$501M
AUM Growth
+$82.2M
(+20%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-20.09%
Top 10 Holdings %
Top 10 Hldgs %
69.75%
Holding
49
New
6
Increased
15
Reduced
6
Closed
4
Top Buys
| 1 |
enGene Holdings
ENGN
|
+$20.8M |
| 2 |
EverCommerce
EVCM
|
+$15.5M |
| 3 |
Sagimet Biosciences
SGMT
|
+$7.15M |
| 4 |
Larimar Therapeutics
LRMR
|
+$4.4M |
| 5 |
Aquestive Therapeutics
AQST
|
+$3.73M |
Top Sells
| 1 |
Toast
TOST
|
+$139M |
| 2 |
Keros Therapeutics
KROS
|
+$11.9M |
| 3 |
Cullinan Oncology
CGEM
|
+$8.43M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$6.63M |
| 5 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
+$6.17M |
Sector Composition
| 1 | Healthcare | 66.92% |
| 2 | Financials | 17.24% |
| 3 | Technology | 14.42% |
| 4 | Industrials | 0.18% |
